Non-Small Cell Lung Cancer in Young Patients: An Analysis of Clinical, Pathologic and TNM Stage Characteristics Compared to the Elderly

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Dell Amore A, Monteverde M, Martucci N, et al. Surgery for non-small cell lung cancer in younger patients: what are the differences? Heart Lung Circ. 2015;24:62–68. doi:10.1016/j.hlc.2014.07.05425130384
   PubMed Web of Science ®Google Scholar
• Liam CK, Lim KH, Wong CMM. Lung cancer in patients younger than 40 years in a multiracial Asian country. Respirology. 2000;5:355–361. doi:10.1111/j.1440-1843.2000.00275.x11192546
   PubMedGoogle Scholar
• Skarin AT, Herbst RS, Leong TL, Bailey A, Sugarbaker D. Lung cancer in patients under age 40. Lung Cancer. 2001;32:255–264. doi:10.1016/S0169-5002(00)00233-611390007
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen SF, Zhen Y, et al. Multicenter analysis of lung cancer patients younger than 45 years in Shanghai. Cancer. 2010;116:3656–3662. doi:10.1002/cncr.2510020564076
   PubMed Web of Science ®Google Scholar
• Prasad R, Verma SK. Comparison between young and old patients with bronchogenic carcinoma. J Cancer Res Ther. 2009;5:31–35. doi:10.4103/0973-1482.4429619293486
   PubMed Web of Science ®Google Scholar
• Radzikowska E, Roszkowski K, Głaz P. Lung cancer in patients under 50 years old. Lung Cancer. 2001;33:203–211. doi:10.1016/s0169-5002(01)00199-411551415
   PubMed Web of Science ®Google Scholar
• Inoue M, Okumura M, Sawabata N, et al. Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry study 2004. Lung Cancer. 2014;83:246–251. doi:10.1016/j.lungcan.2013.11.00724296124
   PubMed Web of Science ®Google Scholar
• Wood DE, Kazerooni EA, Baum SL, et al. Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Ne. 2018;16:412–441. doi:10.6004/jnccn.2018.0020
   PubMed Web of Science ®Google Scholar
• Eric I, Petek EA, Kristek J, Koprivcic I, Babic M. Breast cancer in young women: pathologic and immunohistochemical features. Acta Clin Croat. 2018;57:497–502. doi:10.20471/acc.2018.57.03.1331168183
   PubMed Web of Science ®Google Scholar
• Nowinska K, Ciesielska U, Piotrowska A, et al. MCM5 expression is associated with the grade of malignancy and Ki-67 antigen in LSCC. Anticancer Res. 2019;39:2325–2335. doi:10.21873/anticanres.1334931092424
   PubMed Web of Science ®Google Scholar
• Detterbeck FC. The eighth edition TNM stage classification for lung cancer: what does it mean on main street? J Thorac Cardiovasc Surg. 2018;155:356–359. doi:10.1016/j.jtcvs.2017.08.13829061464
   PubMed Web of Science ®Google Scholar
• Lara MS, Brunson A, Wun T, et al. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California cancer registry analysis. LUNG CANCER. 2014;85:264–269. doi:10.1016/j.lungcan.2014.04.00724878033
   PubMed Web of Science ®Google Scholar
• Igata F, Uchino J, Fujita M, Iwasaki A, Watanabe K. Clinical features of lung cancer in Japanese patients aged under 50. Asian Pac J Cancer Prev. 2016;17:3377. doi:10.7314/apjcp.2016.17.4.211927509978
   PubMedGoogle Scholar
• Lortet-Tieulent J, Soerjomataram I, Ferlay J, et al. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84:13–22. doi:10.1016/j.lungcan.2014.01.00924524818
   PubMed Web of Science ®Google Scholar
• Veness MJ, Delaney G, Berry M. Lung cancer in patients aged 50 years and younger: clinical characteristics, treatment details and outcome. Australas Radiol. 1999;43:328–333. doi:10.1046/j.1440-1673.1999.433666.x10901928
   PubMedGoogle Scholar
• Barbone F, Bovenzi M, Cavallieri F, Stanta G. Cigarette smoking and histologic type of lung cancer in men. Chest. 1997;112:1474–1479. doi:10.1378/chest.112.6.14749404741
   PubMed Web of Science ®Google Scholar
• Kim CH, Lee YA, Hung RJ, et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the international lung cancer consortium (ILCCO). Int J Cancer. 2014;135:1918–1930. doi:10.1002/ijc.2883524615328
   PubMed Web of Science ®Google Scholar
• Chen J. Canadian population risk of radon induced lung cancer—variation range assessment based on various radon risk models. Radiat Prot Dosim. 2017;177:63–68. doi:10.1093/rpd/ncx133
   Web of Science ®Google Scholar
• Al-arydah MT. Population attributable risk associated with lung cancer induced by residential radon in Canada: sensitivity to relative risk model and radon probability density function choices. Sci Total Environ. 2017;596:331–341. doi:10.1016/j.scitotenv.2017.04.06728437651
   PubMed Web of Science ®Google Scholar
• Lin X, Liao Y, Hao Y. The burden of cardio-cerebrovascular disease and lung cancer attributable to PM2.5 for 2009, Guangzhou: a retrospective population-based study. Int J Environ Health Res. 2019;29:582–592. doi:10.1080/09603123.2018.155760530572714
   PubMed Web of Science ®Google Scholar
• Andersen BL, Valentine TR, Lo SB, et al. Newly diagnosed patients with advanced non-small cell lung cancer: a clinical description of those with moderate to severe depressive symptoms. LUNG CANCER. 2020;145:195–204.31806360
   PubMed Web of Science ®Google Scholar
• Cannon-Albright LA, Carr SR, Akerley W. Population-based relative risks for lung cancer based on complete family history of lung cancer. J Thorac Oncol. 2019;14(7):1184–1191. doi:10.1016/j.jtho.2019.04.01931075544
   PubMed Web of Science ®Google Scholar
• Jakobsen JN, Sørensen JB. Clinical impact of ki-67 labeling index in non-small cell lung cancer. Lung Cancer. 2013;79:1–7. doi:10.1016/j.lungcan.2012.10.00823137549
   PubMed Web of Science ®Google Scholar
• Wen S, Zhou W, Li C, et al. Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies. BMC Cancer. 2015;15. doi:10.1186/s12885-015-1524-2
   Web of Science ®Google Scholar
• Martin B, Paesmans M, Mascaux C, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Brit J Cancer. 2004;91:2018–2025. doi:10.1038/sj.bjc.660223315545971
   PubMed Web of Science ®Google Scholar
• Gomes R, Dabó H, Queiroga H, Hespanhol V. Non-small cell lung cancer in young patients – a retrospective analysis of 10 years in a tertiary university hospital. Revista Portuguesa De Pneumologia. 2016;22:125–126. doi:10.1016/j.rppnen.2015.10.00126616684
   PubMed Web of Science ®Google Scholar
• Bourke W, Milstein D, Giura R, et al. Lung cancer in young adults. Chest. 1992;102:1723–1729. doi:10.1378/chest.102.6.17231446479
   PubMed Web of Science ®Google Scholar
• Bryant AS, Cerfolio RJ. Differences in outcomes between younger and older patients with non-small cell lung cancer. Ann Thorac Surg. 2008;85:1739. doi:10.1016/j.athoracsur.2008.01.031
   Web of Science ®Google Scholar